Literature DB >> 11062364

Epidemiology and molecular biology of early prostatic neoplasia.

W A Sakr1, C Ward, D J Grignon, G P Haas.   

Abstract

This paper provides our institutional data with respect to the prevalence of early neoplastic changes within the prostate gland and the age and race distribution of the patients. The changes examined were prostatic intraepithelial neoplasia (PIN) and preclinical (latent) cancers. The literature on the prevalence of these early lesions among different geographic and ethnic groups is summarized, and an abbreviated review of the more common molecular alterations reported at this early phase of prostatic neoplasia is offered.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11062364

Source DB:  PubMed          Journal:  Mol Urol        ISSN: 1091-5362


  6 in total

1.  Evidence supports a faster growth rate and/or earlier transformation to clinically significant prostate cancer in black than in white American men, and influences racial progression and mortality disparity.

Authors:  Isaac J Powell; Cathryn H Bock; Julie J Ruterbusch; Wael Sakr
Journal:  J Urol       Date:  2010-03-17       Impact factor: 7.450

2.  Dietary resveratrol prevents development of high-grade prostatic intraepithelial neoplastic lesions: involvement of SIRT1/S6K axis.

Authors:  Guiming Li; Paul Rivas; Roble Bedolla; Dinesh Thapa; Robert L Reddick; Rita Ghosh; Addanki P Kumar
Journal:  Cancer Prev Res (Phila)       Date:  2012-12-17

3.  Ribosome-inactivating proteins isolated from dietary bitter melon induce apoptosis and inhibit histone deacetylase-1 selectively in premalignant and malignant prostate cancer cells.

Authors:  Su Dao Xiong; Kang Yu; Xin Hua Liu; Li Hui Yin; Alexander Kirschenbaum; Shen Yao; Goutham Narla; Analisa DiFeo; Jian Buo Wu; Yong Yuan; Shuk-Mei Ho; Ying Wai Lam; Alice C Levine
Journal:  Int J Cancer       Date:  2009-08-15       Impact factor: 7.396

4.  Downregulation of vascular endothelial growth factor and induction of tumor dormancy by 15-lipoxygenase-2 in prostate cancer.

Authors:  Yong Tang; Man-Tzu Wang; Yakun Chen; Dianer Yang; Mingxin Che; Kenneth V Honn; Gregory D Akers; Stephen R Johnson; Daotai Nie
Journal:  Int J Cancer       Date:  2009-04-01       Impact factor: 7.396

Review 5.  Importance of Estrogenic Signaling and Its Mediated Receptors in Prostate Cancer.

Authors:  Kin-Mang Lau; Ka-Fai To
Journal:  Int J Mol Sci       Date:  2016-08-31       Impact factor: 5.923

Review 6.  MicroRNAs and prostate cancer.

Authors:  Xu-Bao Shi; Clifford G Tepper; Ralph W Devere White
Journal:  J Cell Mol Med       Date:  2008-07-08       Impact factor: 5.310

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.